Quoin Pharmaceuticals (QNRX) has received written notice from the Listing Qualifications Department of The Nasdaq Stock Market stating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The notification from Nasdaq confirms that for the last 13 consecutive business days, the closing bid price of the Company’s ordinary shares was at or above $1.00 per share. Accordingly, Nasdaq considers the matter closed.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNRX:
- Quoin Pharmaceuticals Ltd – ADR trading resumes
- Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause
- Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series
- Quoin Pharmaceuticals Ltd – ADR trading halted, news pending
- Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested